BioHealth News
ComputChem Launches State-of-the-Art Approach to Predicting pKa Values with New Product: iTitrate®
A powerful web app to help drug designers accurately predict the pKa value of titratable residues December 5, 2023, Baltimore, MD – ComputChem, an…
Read More
Danaher Completes Acquisition of Abcam
WASHINGTON, Dec. 6, 2023 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) ("Abcam"). The acquisition of Abcam…
Read More
Gaithersburg’s Altimmune open to partnerships, deals with drugmakers, says CEO
By Pratik Jain and Khushi Mandowara - Dec 5 (Reuters) - Weight-loss drug developer Altimmune (ALT.O) is open to deals and collaborations with large drugmakers as it actively looks for partners…
Read More
Matan Companies Signs 198,000 SF Full-Building Lease with AstraZeneca in BioHealth Capital Region
Matan Companies, a leading real estate development and investment firm, announced today the successful execution of a full-building lease agreement with AstraZeneca, a global,…
Read More
Industry Leader and Globally Recognized Patient Advocate John F. Crowley Appointed to Lead BIO as President & CEO
Biotech entrepreneur, company founder, tireless patient advocate, and U.S. Navy combat veteran will guide the life science industry in its mission to feed, fuel…
Read More
CarrTech Corp. Poised to Reduce Needle Sticks & Glass Shard Contamination in Medications
Revolutionizing the way healthcare providers administer medicines from glass ampoules FREDERICK, Md., Dec. 4, 2023 /PRNewswire-PRWeb/ -- CarrTech Corp., a woman-owned startup and Qualified Maryland Biotechnology…
Read More
Get Pre-Application Support through the NHLBI Innovator to Entrepreneur Program!
The National Heart Lung and Blood Institute (NHLBI) in partnership with the National Institute of Allergy and Infectious Diseases (NIAID) will be providing training…
Read More
Sara Nayeem, M.D., Experienced Biopharmaceutical Venture Investor, Joins Enavate Sciences as Executive Vice President, Investments
MENLO PARK, Calif., Dec. 4, 2023 /PRNewswire/ -- Enavate Sciences, a portfolio company of Patient Square Capital, is pleased to announce that Sara M. Nayeem, M.D. has joined the…
Read More
Baltimore’s MIRA Pharmaceuticals Releases Breakthrough Data from Artificial Intelligence Simulations
AI Simulation on MIRA1a Showcases Significant Potential Advantages Over Plant-Based Medical Marijuana Related to Anxiety, Appetite and Cognition BALTIMORE, Dec. 4, 2023 /PRNewswire/ -- MIRA Pharmaceuticals, Inc.…
Read More
ATCC Announces Award from NIAID to Consolidate its BEI Resources and NIH HIV Reagent Programs
The Biological and Emerging Infections Research Resources Program (BEI-RRP) contract, which merges the two programs, represents the fourth recompete award with NIAID since 2003.…
Read More
424 Capital Announces Investment in VaLogic
WAKEFIELD, Mass., Nov. 29, 2023 /PRNewswire/ -- 424 Capital announced today that it has completed a significant investment in VaLogic, a leading provider of GMP (Good…
Read More
citybiz Interviews Richard Hughen, CEO of Linshom Medical
Richard Hughen’s thirty years of professional medical device experience spans three Fortune 500 and four start-up companies with two successful exits to date. He…
Read More
MIMETAS and Yamaha Motor Sign Joint Marketing Agreement to Advance Automated Human Disease Model Applications for Drug Development
LEIDEN, the Netherlands, November 29, 2023 / B3C newswire / -- MIMETAS, a leader in human 3D disease modeling, and Yamaha Motor Co., Ltd., a…
Read More
REGENXBIO Announces Dose Escalation in AFFINITY DUCHENNE® Trial
ROCKVILLE, Md., Nov. 29, 2023 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that the first patient received RGX-202 at dose level 2 in the Phase I/II AFFINITY…
Read More
Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)
GAITHERSBURG, Md., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness…
Read More